Literature DB >> 20580289

Novel large deletions in the human alpha-globin gene cluster: Clarifying the HS-40 long-range regulatory role in the native chromosome environment.

Andreia Coelho1, Isabel Picanço, Filomena Seuanes, Maria Teresa Seixas, Paula Faustino.   

Abstract

Globin genes, which encode the protein subunits of hemoglobin (Hb), are organized in two different gene clusters and present a coordinated and differential pattern of expression during development. Concerning the human alpha-globin gene cluster (located at chromosome region 16p13.3), four upstream highly conserved elements known as multispecies conserved sequences (MCS-R1-4) or DNase I hypersensitive sites (HSs) are implicated in the long-range regulation of downstream gene expression. However, only the absence of the MCS-R2 site (HS-40) has proven to drastically downregulate the expression of those genes, and consequently, it has been regarded as the major and crucial distal regulatory element. In this study, Multiplex Ligation-dependent Probe Amplification was used to screen for deletions in the telomeric region of the short arm of chromosome 16, in an attempt to explain the alpha-thalassemia or the HbH disease present in a group of Portuguese patients. We report four novel and five uncommon deletions that remove the alpha-globin distal regulatory elements and/or the complete alpha-globin gene cluster. Interestingly, one of them occurred de novo and removes all HSs except HS-10, while other eliminates only the HS-40 site, the latter being replaced by the insertion of a 39 nucleotide orphan sequence. Our results demonstrate that HS-10 alone does not significantly enhance the alpha-globin gene expression. The absence of HS-40 in homozygosity, found in a patient with Hb H disease, strongly downregulates the expression of alpha-globin genes but it is not associated with a complete absence of alpha-globin chain production. The study of naturally occurring deletions in this region is of great interest to understand the role of each upstream regulatory element in the native human erythroid environment. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580289     DOI: 10.1016/j.bcmd.2010.05.010

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

1.  Two atypical forms of HbH disease in Sardinia.

Authors:  Maria Elisabetta Paglietti; Maria Carla Sollaino; Daniela Loi; Francesca Sarra; Eleonora Zaccheddu; Renzo Galanello
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

2.  The molecular basis of α-thalassemia.

Authors:  Douglas R Higgs
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

3.  Development and clinical implementation of a combination deletion PCR and multiplex ligation-dependent probe amplification assay for detecting deletions involving the human α-globin gene cluster.

Authors:  Benjamin R Kipp; Samantha E Roellinger; Patrick A Lundquist; W Edward Highsmith; D Brian Dawson
Journal:  J Mol Diagn       Date:  2011-06-25       Impact factor: 5.568

4.  Characterization of two novel Alu element-mediated α-globin gene cluster deletions causing α0-thalassemia by targeted next-generation sequencing.

Authors:  Zhiming Li; Xuan Shang; Shiqiang Luo; Fei Zhu; Xiaofeng Wei; Wanjun Zhou; Yuhua Ye; Tizhen Yan; Ren Cai; Xiangmin Xu
Journal:  Mol Genet Genomics       Date:  2020-01-02       Impact factor: 3.291

Review 5.  α-Globin as a molecular target in the treatment of β-thalassemia.

Authors:  Sachith Mettananda; Richard J Gibbons; Douglas R Higgs
Journal:  Blood       Date:  2015-04-13       Impact factor: 22.113

Review 6.  Uncovering enhancer functions using the α-globin locus.

Authors:  Douglas Vernimmen
Journal:  PLoS Genet       Date:  2014-10-16       Impact factor: 5.917

7.  Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.

Authors:  Sachith Mettananda; Chris A Fisher; Deborah Hay; Mohsin Badat; Lynn Quek; Kevin Clark; Philip Hublitz; Damien Downes; Jon Kerry; Matthew Gosden; Jelena Telenius; Jackie A Sloane-Stanley; Paula Faustino; Andreia Coelho; Jessica Doondeea; Batchimeg Usukhbayar; Paul Sopp; Jacqueline A Sharpe; Jim R Hughes; Paresh Vyas; Richard J Gibbons; Douglas R Higgs
Journal:  Nat Commun       Date:  2017-09-04       Impact factor: 14.919

8.  ATR-16 syndrome: mechanisms linking monosomy to phenotype.

Authors:  Christian Babbs; Jill Brown; Sharon W Horsley; Joanne Slater; Evie Maifoshie; Shiwangini Kumar; Paul Ooijevaar; Marjolein Kriek; Amanda Dixon-McIver; Cornelis L Harteveld; Jan Traeger-Synodinos; Andrew O M Wilkie; Douglas R Higgs; Veronica J Buckle
Journal:  J Med Genet       Date:  2020-01-31       Impact factor: 6.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.